Stopped: Change in study design and inability to recruit participants
This study is designed to evaluate specific factors in mitochondria that may precipitate premature aging and physical weakness in HIV patients. Angiotensin receptors 1 and 2 (AT1R and AT2R) are found in virtually every cell type. This study will evaluate how the relationships among these receptors in immune and skeletal muscle cells change with HIV, and how these changes might trigger mitochondrial dysfunction, declines in muscle strength, and cellular decline in people living with HIV.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change From Baseline in 400m Walk
Timeframe: 3, 6, and 9 months post-enrollment
Change From Baseline in Grip Strength
Timeframe: 3, 6, and 9 months post-enrollment
Change From Baseline in Quantity of AT1R and AT2R on Monocytes
Timeframe: 3, 6, and 9 months post-enrollment